If your institution subscribes to this resource, and you don't have a MyAccess Profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
Antineoplastic, multikinase inhibitor (FLT3, AXL, ALK)164
FLT3-positive acute myeloid leukemia†
Chapter 67. Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules > Midostaurin
eChapter 2018: The Goodman & Gilman Year in Review New and Noteworthy FDA Approvals